115 related articles for article (PubMed ID: 3053205)
1. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
[TBL] [Abstract][Full Text] [Related]
2. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies.
Shaw P; Buckman R; Law J; Baumal R; Marks A
Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of ovarian carcinoma cells in serous effusions.
Cuijpers VM; Boerman OC; Salet van de Pol MR; Vooijs GP; Poels LG; Ramaekers FC
Acta Cytol; 1993; 37(3):272-9. PubMed ID: 8498129
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
Ghosh AK; Mason DY; Spriggs AI
J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies.
Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY
J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183
[TBL] [Abstract][Full Text] [Related]
7. Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.
Mottolese M; Venturo I; Rinaldi M; Lopez M; Bigotti G; Benevolo M; Natali PG
Br J Cancer; 1997; 75(4):572-8. PubMed ID: 9052413
[TBL] [Abstract][Full Text] [Related]
8. Ca2 and Ca3. New monoclonal antibodies evaluated as tumor markers in serous effusions.
Bramwell ME; Ghosh AK; Smith WD; Wiseman G; Spriggs AI; Harris H
Cancer; 1985 Jul; 56(1):105-10. PubMed ID: 2408723
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma.
Delahaye M; Hoogsteden HC; Van der Kwast TH
J Pathol; 1991 Oct; 165(2):137-43. PubMed ID: 1744800
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnostic significance of the paucity of HLA-I antigens on metastatic breast carcinoma cells in effusions.
Magyarosy E; Martin WJ; Chu EW; Martin SE
Pathol Oncol Res; 1999; 5(1):32-5. PubMed ID: 10079375
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of the determination of carcinoembryonic antigens with monoclonal antibodies in abdominal and pleural effusion].
Fei XF
Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):28-9, 62. PubMed ID: 2379252
[TBL] [Abstract][Full Text] [Related]
12. Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma.
Osinaga E; Pancino G; Beuzelin M; Babino A; Rodriguez D; Robello C; Tiscornia A; Phillips E; Bourguignat A; Roseto A
Cancer; 1992 Apr; 69(7):1745-9. PubMed ID: 1551059
[TBL] [Abstract][Full Text] [Related]
13. Use of a pool of monoclonal antibodies in diagnosing cells from serous cavities.
Cappellari A; Bagarella M; Ménard S; Calabrese M; Colnaghi MI
Tumori; 1993 Jun; 79(3):211-3. PubMed ID: 8236507
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions].
Gaulier A; Cava E; Chosia MC; Pore G; Marsan C
Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies to human squamous cell carcinoma of the lung and their application to tumor diagnosis.
Kyoizumi S; Akiyama M; Kouno N; Kobuke K; Hakoda M; Jones SL; Yamakido M
Cancer Res; 1985 Jul; 45(7):3274-81. PubMed ID: 4005855
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
Afify A; Zhou H; Howell L; Paulino AF
Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies.
Ménard S; Rilke F; Della Torre G; Mariani-Costantini R; Regazzoni M; Tagliabue E; Alasio L; Colnaghi MI
Am J Clin Pathol; 1985 May; 83(5):571-6. PubMed ID: 3887893
[TBL] [Abstract][Full Text] [Related]
18. A new marker for human cancer cells. 3. Immunocytochemical detection of malignant cells in serous fluids with the Ca1 antibody.
Woods JC; Spriggs AI; Harris H; McGee JO
Lancet; 1982 Sep; 2(8297):512-4. PubMed ID: 6125677
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum CA 125 levels in patients with benign ascitic or pleural effusions.
Mezger J; Wilmanns W; Lamerz R
Tumour Biol; 1988; 9(1):47-52. PubMed ID: 3163160
[TBL] [Abstract][Full Text] [Related]
20. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
